| GKB Ophthalmics Ltd | Industry : (FMCG) | |
|---|---|---|
|
BSE Code : 533212 |
NSE Symbol : GKB |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE265D01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 28.41 |
Market Cap(₹Cr) : 32.10 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 6.40 | 4.36 | 6.11 | 8.77 | 8.43 | 7.45 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 6.40 | 4.36 | 6.11 | 8.77 | 8.43 | 7.45 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.99 | 3.54 | 1.37 | 0.07 | 0.01 | 1.81 |
| Total Income | 7.39 | 7.90 | 7.47 | 8.85 | 8.44 | 9.26 |
| Total Expenditure | 8.34 | 5.71 | 6.73 | 9.62 | 9.61 | 8.27 |
| PBIDT | -0.95 | 2.19 | 0.75 | -0.77 | -1.18 | 0.99 |
| Interest | 0.32 | 0.60 | 0.57 | 0.68 | 0.60 | 0.48 |
| PBDT | -1.27 | 1.59 | 0.17 | -1.46 | -1.77 | 0.51 |
| Depreciation | 0.66 | 0.68 | 0.68 | 0.67 | 0.66 | 0.67 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.04 | -0.07 | 0.02 | 0.02 | 0.04 | 0.01 |
| Reported Profit After Tax | -1.88 | 0.98 | -0.52 | -2.14 | -2.48 | -0.17 |
| Extra-ordinary Items | -1.49 | -0.30 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.39 | 1.28 | -0.52 | -2.14 | -2.48 | -0.17 |
| EPS (Unit Curr.) | -3.74 | 1.95 | -1.04 | -4.25 | -4.92 | -0.33 |
| EPS (Adj) (Unit Curr.) | -3.74 | 1.95 | -1.04 | -4.25 | -4.92 | -0.33 |
| Calculated EPS (Unit Curr.) | -3.74 | 1.95 | -1.04 | -4.25 | -4.92 | -0.33 |
| Calculated EPS (Adj) (Unit Curr.) | -3.74 | 1.95 | -1.04 | -4.25 | -4.92 | -0.33 |
| Calculated EPS (Ann.) (Unit Curr.) | -14.94 | 7.78 | -4.15 | -17.01 | -19.68 | -1.33 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -14.94 | 7.78 | -4.15 | -17.01 | -19.68 | -1.33 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -14.84 | 50.23 | 12.27 | -8.78 | -14.00 | 13.29 |
| PBDTM(%) | -19.84 | 36.47 | 2.78 | -16.65 | -21.00 | 6.85 |
| PATM(%) | -29.38 | 22.48 | -8.51 | -24.40 | -29.42 | -2.28 |
